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THE EQUALITY TOOLKIT: PRACTICAL SKILLS FOR LGBTQ AND 
DSD-AFFECTED PATIENT CARE
PREFACE
WHAT IS THE PURPOSE OF THE eQUALITY TOOLKIT?
 is manual will help providers build a foundation of inclusive clinical skills to competently care 
for lesbian, gay, bisexual, transgender, and queer-identi ed (LGBTQ) patients and individuals 
born with di erences of sex development (DSD, sometimes called intersex). Although this toolkit 
was designed for medical students, any healthcare provider who wants to learn inclusive clinical 
skills can bene t from this manual. Other published resources address LGBTQ/DSD health and 
clinical skills comprehensively (see Appendix A).  e purpose of this manual is to provide a brief 
primer that is accessible to all medical students with actionable steps to improve clinical care. It 
was speci cally written for use at the University of Louisville School of Medicine; therefore, some 
resources or laws may be region/city speci c. However, most of the content is applicable to any 
provider caring for LGBTQ/DSD patients.
WHY IS THIS MANUAL NEEDED?
Simply, this manual addresses gaps in healthcare provider training in caring for LGBTQ/DSD 
communities.  ese populations experience repeated instances of stigma and discrimination 
related to their identities, with consequent health and healthcare disparities that knowledgeable 
1
The number of people who identify as LGBTQ is growing, 
including 7.3% of millennials.1 DSD is estimated to a ect 
1.7% of births.2,3 These individuals are our patients, and it is 
our responsibility to learn how to provide quality care for 
them. 
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healthcare providers can help to address.4-9 In 2015, the University of Louisville School of Med-
icine (ULSOM) established eQuality (louisville.edu/medicine/equality/), an inclusive LGBTQ/
DSD health training program that was integrated across the mainstream medical student curric-
ulum.10 After launching eQuality, we realized our students needed more clinical skills training to 
translate classroom learning into patient care. Although the focus of this manual is LGBTQ/DSD 
health, much of this content is applicable to all patients and can be incorporated broadly.
HOW TO USE THIS MANUAL
 is manual has been used to train medical students in a classroom setting. However, it can func-
tion independently as a clinical skills supplement for practicing providers.  Its  ve sections address 
the main sources of provider-driven health disparities and biases for the LGBTQ/DSD commu-
nities.  is manual could be used as a supplement to a longitudinal clinical skills training course 
during medical school or in stand-alone LGBTQ/DSD health training. Although it is a primer, it 
may also be appropriate for graduate medical education (GME) training and as a faculty devel-
opment tool. As you encounter terminology that is not familiar to you, please see the glossary in 
Appendix B for de nitions.  
LIMITATIONS
 e purpose of this manual is to provide a brief introduction for students, and making this 
practical necessitates the distillation of many complex subjects. For instance, we use the umbrella 
terms LGBTQ/DSD in this manual, which do not re ect the vast diversity of sexual and gen-
der minority communities (see  gure below and Appendix B for examples of sexual and gender 
identities).  It is important to remember that terminology is  uid and ever changing.  erefore, 
the best strategy for providers is to have an open dialogue with patients to learn the words they 
use. Appendix A contains a list of resources for more comprehensive consideration of the topics in 
this manual.
Supporting research informs our recommendations, but many federal guidelines lag behind the 
expertise of providers who work extensively in LGBTQ/DSD health. We provide peer-reviewed 
citations in this manual to help inform your decision-making. Reasons to depart from guidelines 
include 1) the lack of an apropos guideline for your patient, and 2) the need for shared deci-
sion-making with the patient (e.g., to still prescribe estrogen in the context of a history of ath-
erosclerotic cardiovascular disease). If departing from guidelines, a physician should be aware of 
LGBTQ/DSD health and healthcare disparities are staggering, including:
—LGB individuals are as much as 2.5x likelier to smoke11
—40% of transgender individuals attempt suicide12
—Cardiovascular disease risk is 2x higher for LGB adults13
—LGBTQ individuals are likelier to be uninsured than others4 
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how other considerations, such as insurance coverage, may in uence these decisions (see Part IV). 
Finally, LGBTQ/DSD health is an evolving  eld, and the authors will make e orts to periodically 
update this manual with current information.  e information in the following sections
represents best practice as of the time of this writing.
PART I: INCLUSIVE COMMUNICATION SKILLS
CREATING AN ACTIVE PARTNERSHIP WITH THE PATIENT
Many members of the LGBTQ/DSD-a ected community have had previous negative experiences 
within the healthcare system.5,12,14,15 One of the provider’s responsibilities is to ensure that the pa-
tient’s previous experiences—both in life and in health care—are considered when discussing dif-
ferent treatment options. LGBTQ individuals comprise approximately 5% of the U.S. population 
and this proportion is growing,1 and these best practices can therefore have a substantial impact.
An active partnership can be developed by asking a patient open-ended questions such as “Tell 
me about your pain” versus “Does this hurt?”16,17  e former allows the patient to elaborate with 
more insightful responses. Close-ended questions, while more direct, require the provider to infer 
information about the patient. When provider assumptions about a patient’s sexual or gender 
identity are incorrect, the patient is left having to choose between correcting the provider or leav-
ing the mistake unaddressed, resulting in suboptimal care that contributes to health disparities. 
 e sections below will help providers develop active partnerships will all patients.
Providers can encourage openness with all patients by intentionally explaining provider-patient 
con dentiality, which is particularly important for patients who have previously endured bias 
and discrimination. Establishing trust by ensuring con dentiality can be especially important for 
gathering an accurate sexual history, regardless of patient identity. Patients should be explicitly 
communication skills
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told what information will be recorded in their medical record, if and how this information will 
be shared (e.g., with insurance companies), and when con dentiality cannot be protected (e.g., 
mandatory reporting requirements for some diseases, abuse, and the potential for harm to self and 
others). Providers should seek permission from the patient to include identifying information in 
the medical record.
AVOIDING ASSUMPTIONS
Knowing about a patient is necessary to provide accurate, quality care. A patient’s identities, 
attractions, and behaviors all impact health risks and social-behavioral determinants of health, 
such as employment or housing access.  e LGBTQ/DSD community also intersects with all 
races, ages, and cultures. When meeting a new patient, it is not possible to know the person’s 
sexual orientation or gender identity by appearance. To avoid assumptions about sexual and 
gender identity, providers must ask, and research shows that patients want physicians to do so!18,19 
(See page 7 for an example of dialogue.) Inclusion is the best way to start a successful relationship 
with LGBTQ/DSD patients, and these steps are no cost to non-LGBTQ/DSD patients because 
common questions/discussions can be framed in an inclusive manner that is appropriate for all 
patients. 
Furthermore, labels often mean di erent things to di erent people, and occasionally identities 
may not match behavior.  Studies have found that some straight-identi ed men engage in same-
sex sexual behavior.20 Similarly, higher pregnancies have been documented among lesbian-iden-
ti ed youth, possibly because providers do not provide contraceptive counseling to individuals 
assumed to engage only in same-sex behavior.21 Behavior that is discordant with identity would 
not be captured by an intake form asking only for sexual orientation.  is highlights the impor-
tance of understanding not just the identities but also the behaviors of patients, a best practice 
that holds true of all patients, not just patients who identify as LGBTQ/DSD.  Such biases in the 
healthcare system can impact patient care.
Considerations should be made for LGBTQ and DSD-a ected 
patients, including youth, who may be concerned about 
being unintentionally “outed” to others or parents. 
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INCLUSION ON FORMS AND IN CONVERSATION
Inclusive intake forms help to make the collection of this information commonplace and give 
providers more context to the patient’s background. Providers may also rotate or work at lo-
cations that do not have inclusive registration forms. We suggest talking to administration to 
address this—prompt attention can make a meaningful di erence—and there are many templates 
available (see resources in Appendix A). Examples of typical registration form questions and more 
inclusive options can be seen on the following page.
Asking detailed information on an intake form does not discriminate against the majority because 
everyone has a sexual orientation and gender identity to disclose. During the patient/physician 
visit, providers will want to ask the patient how they identify. Asking again in person is important 
because some patients will not disclose sexual orientation and/or gender identity on a form that 
could be linked to their health record because of discrimination concerns. 
Collecting and using preferred names avoids unintentionally 
“outing” transgender patients (to other patients in the waiting 
rooms, sta  not on the care team, etc.).22 
communication skills
Some patients will not want to disclose sexual orientation and/or 
gender identity on a form that could be linked to their health record. 
Discrimination is real for many LGBTQ community members (the state of 
Kentucky, for example, does not protect LGBTQ people from employment 
or housing discrimination at the time this manual was written). Ideally, 
we are moving toward a society that treats all people equally regardless 
of identity, but until this point, some patients may be hesitant to put 
sensitive information on o icial forms. 
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Because discussing this important information is not yet commonplace, providers may want to 
explain to patients why they ask for it. It is important to ask these questions to every patient—re-
gardless of whether or not a provider thinks the patient is straight, cisgender, gender conforming, 
or has a history of opposite sex activity. Asking all patients addresses the provider’s own biases, 
assumptions, and stereotypes.7 Practicing these questions will make the provider feel more at 
ease asking them over time and will normalize the conversation with all patients. Asking patients 
about same-sex sexual behavior or attraction typically results in larger population estimates of 
sexual minority status compared to asking people whether they identify as part of the LGBTQ 
community.23 
“I don’t want to o end my patients.” Many providers hesitate 
to ask about identities out of concern for o ending non-LGBTQ/
DSD patients. These concerns are largely unwarranted because 1) 
all patients have answers to these identity questions, and 2) most 
patients understand if providers approach this conversation as 
a routine part of the patient history. If a patient were to respond 
negatively, providers should reiterate that every patient is asked 
these questions. Here is an example dialogue:
Provider: “I ask these questions of all of my patients so that I can 
give you the best care possible. What pronouns do you use?”
Patient: “Don’t I look like a woman to you?”
Provider: “Of course. These are questions that I ask all of my 
patients to make sure I understand who they are. I’ll use she,” and 
then continue to the next question. 
communication skills
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Below are suggestions for taking an inclusive medical history in person to help avoid assumptions 
(see Part V for inclusive language choices for speci c body parts and bodily processes).  ese 
questions also signal to patients that they can talk to a provider in the future about any concerns.
eQuality Toolkit
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CONVERSATIONS WITH LGBTQ/DSD-AFFECTED YOUTH
Healthcare providers can assist youth who were born with a DSD, identify as LGBTQ, or who are 
questioning their sexual or gender identities. For DSD-a ected individuals, sexual orientation and 
gender identity cannot be assumed by the provider; this highlights the importance of having these 
discussions with all patients. Provider support is particularly crucial if the patients have insu  -
cient support at home and/or school. Adverse childhood experiences (ACEs), including abuse, 
household dysfunction, abandonment, and rejection are common (although not universal) for 
LGBTQ youth, and these experiences often lead to adverse mental and physical health e ects.25 
Providers can help determine if young patients are at risk. Providing a supportive, welcoming 
environment is the  rst step. Providers may ask to discuss some more sensitive topics without the 
parent present to reduce the patient’s stress and allow for a more comfortable, honest discussion.7  
Before disclosure, providers should understand and explain to the youth patient what obligation 
they have to notify parents and also what con dentiality a provider can give to the patient. Laws 
governing minor consent and parental access to health information of minors vary by state. In 
Kentucky, for instance, patients under 18 years old can seek treatment for STIs, contraception, 
pregnancy (not including sterilization or abortion), and substance abuse without parental/guard-
ian noti cation.31 Age of consent laws also vary by state, but providers are mandated to report 
minors who disclose sexual activity before this age (as well as any signi cant safety concerns) to 
child protective services. Gender identity and sexual orientation are not speci cally covered under 
the law, but are usually regarded by healthcare providers as protected information that would not 
be discussed with a parent without the consent of the patient. Optimal care for the minor patient 
usually includes family support and disclosure. However, due to family rejection and domestic 
violence concerns for LGBTQ youth, the safety of the patient following disclosure has to be bal-
anced with the wish of the provider to inform parents.    
communication skills
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REFERRAL NETWORKS AND BEST PRACTICES
Many LGBTQ patients and patients with a DSD have experienced healthcare providers refusing 
to care for them, refusing requested care, and/or committing micro or overt aggressions that reject 
their humanity.12,32  ese incidents occur at a time that patients are incredibly vulnerable, such as 
going to the doctor’s o  ce, emergency room, hospital, or operating room.
Medical students desire to provide e ective, evidenced-based, compassionate, a  rmative care to 
LGBTQ patients,33 but medical education has not traditionally provided an e ective framework 
for physicians to provide LGBTQ health care.34  is manual is clear in its intent to positively 
impact patient care by providing those willing and invested in improving health outcomes for 
LGBTQ/DSD patients the information necessary for them to care for their patients. If providers 
work with others who choose to refer LGBTQ/DSD patients, they should ensure it is done with 
the patient’s well-being in mind. It is not appropriate for the provider to describe personal beliefs 
or make judgments that contribute to bias and discrimination, which can thus discourage the 
patient from seeking future preventive and diagnostic health care and do harm to the patient. 
Providers should use neutral, nonjudgmental language that assures patients that their needs will 




Even if a provider creates an inclusive space, issues with other members of the team—from the 
front desk to nursing sta  to attending physicians—can create a hostile or even dangerous envi-
ronment for patients. Many patients who are LGBTQ/DSD report experiencing microaggressions 
(comments that are subtly or unconsciously prejudiced and hurtful) in healthcare o  ces, as well 
as overt harassment and discrimination in some instances (such as verbal abuse, rough physical 
exams, or refusal to treat).12 Healthcare providers have a responsibility to ensure that patients 
experience a welcoming environment. As a bystander/upstander and ally, every provider should 
be ready to intervene on behalf of an LGBTQ/DSD patient (or co-worker, etc.). Providers should 
practice supporting the person targeted by the microaggression in order to prioritize that indi-
vidual’s well-being, and then address the source (taking advantage of opportunities to educate 
others).  Here are some examples of common microaggressions and possible responses:
Medical students may have to address microaggressions—often made unintentionally—from 
higher-ups, such as residents and attending physicians. If a student feels comfortable “teaching 
up” in a situation, they may explain to the team how the microaggression is o ensive and o er 
more inclusive options. If the student is not comfortable in this role in the setting of the micro-
aggression, it is important to give feedback to a trusted supervisor or administrator in the clinical 
or educational environment (for example, a clerkship director or coordinator) so that additional 
education can occur. 
communication skills
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PART II: GENDER-AFFIRMING CARE
AVOIDING ASSUMPTIONS ABOUT TRANSITIONING
Gender-a  rming care is appropriate and supportive care for the patient’s complete gender identi-
ty. Establishing whether a patient is cisgender, transgender, or was born with a DSD is best done 
through the two-step gender identity questions (see Part I) to determine whether gender identity 
(step one) matches sex assigned at birth (step two), and to determine what pronouns the patient 
uses.  is section discusses additional considerations for e ectively providing care for patients 
whose gender identity does not match their sex assigned at birth.  is section will refer to patients 
seeking this care using the umbrella terms transgender and DSD for brevity, but there are many 
gender identities that apply here such as nonbinary, genderqueer, gender  uid, and more (See 
Appendix B).
Below we discuss medical and surgical interventions that can help a  rm transgender patients’ 
identities.  e starting place for gender-a  rming care is to realize, however, that not every pa-
tient’s transition will be the same. Consider the parallel between transitioning and starting a fam-
ily—not every person wants children, and sometimes life circumstances take priority. Similarly, 
some transgender patients never want medical or surgical interventions as part of their transition, 
and sometimes insurance issues complicate these choices (see Part IV).  ere is no single path 
that any transgender patient should follow, so it is best to ask open-ended questions like “can you 
tell me about your transition goals?” when taking a history and discussing gender identity and/
or goals of hormone use or surgery.  is allows the patient to take charge of their personal aims 
and allows the provider to address any questions the patient has. With the wide array of online 
resources for transgender health, many patients are well informed about their options and goals. 




 e World Professional Association for Transgender Health (WPATH), the international body 
of experts on transgender care, has determined that gender-a  rming procedures are medically 
necessary for those transgender patients who desire them as part of their transition.8 Ultimately 
the risks of feminizing and masculinizing therapy need more data to be conclusive, but there is 
an overwhelming bene t to addressing gender dysphoria for transgender patients. Hormonal in-
terventions used in transition are associated with decreased depression and anxiety.36 Recent data 
show that 40% of transgender people attempt suicide,12 so many LGBTQ providers see suicidal 
ideation risk as a more pressing health issue than possible side e ects of hormone therapy.  e key 
point is for providers to become informed and prescribe gender-a  rming care based on the 
transition desires of their patients!
PATIENTS BORN WITH DSD
DSD-a ected individuals may not have the anatomy and/or hormonal composition typical 
of a natal male or natal female. DSDs are diverse, and knowing an individual’s anatomy and 
hormones is necessary to provide appropriate preventive screening and counseling. For some 
DSD-a ected patients, gender identity will have been determined during infancy or childhood 
by their providers and/or parents, although advocates are working hard to change this.5 Many 
DSD-a ected individuals have had prior negative healthcare experiences because their family and 
providers did not explain their condition or failed to discuss all available treatment options,37 and/
or because of voyeurism (unnecessary exams or additional members of the healthcare team present 
Some care guidelines recommend that a person live openly within 
the new or desired gender identity for a set period of time and/or 
provide a referral letter from a mental health professional before 
providers prescribe medications or surgery for gender-a irming 
care. However, this recommendation is evolving, and more recent 
practices focus on enhancing self-esteem and mental well-being 
by partnering with the patient to prescribe desired treatments 
earlier to help match the patient’s internal experience with their 
desired external appearance more completely and expeditiously. The 
informed consent process allows providers to develop a plan with 
the patient who demonstrates an understanding of risks, benefits, 
and implications of treatment; providers document the conversation 
in the medical record to indicate informed consent was obtained 
(patient signature not required). 
gender-a irming care
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“to learn”).38-39 Healthcare providers should fully disclose the DSD diagnosis and all potential 
treatment options from the outset, and ask patients about their prior healthcare experiences.  is 
approach supports the development of a shared decision-making model that is in the best interest 
of the patient. Finally, it is important to remember that having a DSD does not determine a 
patient’s sexual orientation, attraction, or sexual behavior. 
HORMONE THERAPY
 e purpose of hormone therapy is to alter secondary sex characteristics to more closely match a 
person’s gender identity rather than their sex assigned at birth. Not all patients desire hormones 
as part of their transition. For those who do, people who identify on the male-to-female spectrum 
typically take estrogen and antiandrogens (which reduce the dose of estrogen needed),40 while 
people on the female-to-male spectrum typically take testosterone.41 Some physical changes are 
irreversible, and thus patients should be informed about this as part of the informed consent 
process before beginning hormone therapy. Special considerations for transitioning prior to the 
onset of puberty are addressed separately below. Although the timeline of the physical e ects of 
hormone therapy are variable, most changes occur in two years.  e WPATH Standards of Care8 
(SOC) detail expected onset times, maximum e ect, and reversibility (and also note that a new 
SOC revision is expected soon with updates since the 2012 version 7).  e Center of Excellence 
for Transgender Health also has detailed feminizing and masculinizing dosage guidelines.6
Who can administer hormones? When approaching a general practitioner for a hormone 
prescription, many transgender patients are “handed o ” to endocrinologists because the provid-
er feels they lack the knowledge to administer and monitor hormones. Referrals place a burden 
on the patient, and many experts assert that hormone therapy does not need to be performed 
speci cally by an endocrinologist.6 Primary care physicians, obstetrician-gynecologists, nurse prac-
eQuality Toolkit
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titioners, and endocrinologists have the capacity to administer gender-a  rming hormones, and 
many have experience with the hormones in other contexts (e.g., contraception or menopause).42 
What are the risks of hormone therapy? A major barrier to care is providers’ overestimation of 
cross-sex hormone therapy risks, which is usually related to a lack of clinical experience or train-
ing with this practice. Introducing hormones in any person comes with risks, but risks are not 
known to be higher for transgender patients. For instance, estrogen carries a risk of blood clots 
whether it is used in a cisgender female patient (FSAAB) or transgender female patient (MSAAB), 
with oral hormones being riskier than injections for both.43  e risks of hormone therapy are 
often cited as a reason for a provider not to initiate hormone therapy or to refer the patient to 
an endocrinologist. Often this is unfounded—few data de nitely show increased risk. Results 
from comprehensive studies, such as the recently established Study of Transition, Outcomes and 
Gender (STRONG),44 are needed to determine the actual long-term risks of hormone therapy to 
transgender patients.6,8
It is the provider’s responsibility to inform the patient of possible risks to ensure a patient’s in-
formed consent before starting hormone therapy. However, requiring patients to continually see a 
specialist for gender-a  rming care can create healthcare disparities by placing a greater burden on 
the patient through fractured and delayed care, which can contribute to poor mental health out-
comes and even suicide. In some cases, it may be desirable for the provider to consult an endocri-
nologist or subspecialist to  rst create an overall plan of care, but a competent primary care doctor 




Some transgender patients may desire irreversible surgical procedures to obtain physical features 
that more closely align with their gender identity. Note that these surgeries include a wide range 
of possible procedures, including several that are not speci c to transgender patients (e.g., hyster-
ectomy).40,41 Possible surgical procedures also include more than just genital removal or recon-
structive surgeries. A good understanding of each patient’s pre- and postsurgical anatomy is cru-
cial to guide routine preventive care, screening decisions, and diagnostic care decisions if problems 
occur in the future. It is crucial that each patient’s medical record re ect that individual’s pre- and 
postsurgical anatomy so that it can be considered by all care providers, such as when an additional 
provider is covering for the primary provider, or is consulted in some aspect of the patient’s care. 
 e e ect of gender-a  rming surgery on screening and preventive care will be addressed in Part 
III. Transgender patients may consider any (or none) of the following surgical interventions:
eQuality Toolkit
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CONSIDERATION FOR TRANSGENDER AND DSD-AFFECTED YOUTH
Transgender youth who have not yet experienced puberty may bene t from starting hormone 
therapy before innate hormones change secondary sex characteristics in a way that does not 
match the youth’s gender identity. Many transgender adolescents will desire puberty blockers and 
bene t from intensive counseling and support as they consider their desired goals of transition. 
Puberty blockers can be advantageous since they prevent physical changes associated with innate 
hormones.   ey can allow questioning youth time to explore their gender development, and the 
e ects are reversible should a patient choose to discontinue their gender transition.45 
 e process of puberty varies for individual adolescents, so timing of hormone administration 
can be di  cult to determine. It may be more desirable for a pediatric endocrinologist to manage 
hormones for youth patients since puberty is being initiated with hormones, and hormone levels 
in children/adolescents di er from those in adults—so standard reference ranges may not apply. 
However, there are many circumstances in which a highly quali ed and experienced primary 
care provider can manage and/or partner with a pediatric endocrinologist for the care of young 
patients. Some organizations suggest that hormone therapy for adolescents can be managed by a 
quali ed primary care provider similar to the manner in which it is managed for adults.6 Howev-
er, this is not currently the norm.
When a DSD is identi ed for an infant or child, the individual with the DSD is unable to make 
an informed decision or consent to treatment. In the past, parents and/or providers have been 
given the responsibility for making this important decision, but current providers for DSD-a ect-
ed patients advocate that any nonurgent procedures—particularly those that are irreversible, such 
as surgery for ambiguous genitalia—be delayed until the child is old enough to make an informed 
decision about gender identity.46 Providers treating a child with DSD should consider the current 
well-being of the child and that of the future adult, the child’s future right to be informed and in 
control of their own healthcare decisions, and the well-being of the child-parent relationship.46
gender-a irming care
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Learning a patient’s gender identity is a two-step process: establishing 
sex assigned at birth and establishing how the patient identifies. Sex 
assigned at birth is vital for providing sex-specific care. A irming a 
patient’s identity (e.g., by using the pronouns the patient uses—such as 
he, she, or they) shows respect and builds a trusting relationship that will 
keep the patient engaged in the healthcare system. The goal is to reduce 
health and healthcare disparities, and facilitating a positive patient-
centered relationship through understanding and a irming patients’ 
identities supports this goal.
If a provider misgenders a patient, respectfully acknowledge the 
mistake to indicate that it was noticed and unintentional, correct the 
mistake, and continue with the patient encounter while ensuring that 
a irming language is used. The provider can apologize if desired, 
although lingering on the mistake can be counterproductive because 
the conversation becomes centralized on the person’s gender rather 
than on the person’s care. This process can also be applied to mistaken 
assumptions about sexual orientation, such as a partner’s gender. 
However, asking all patients about gender identity and sexual orientation 




PART III: PREVENTIVE CARE
FRAMEWORK FOR TRAUMA-INFORMED CARE
Many individuals experience repeated harassment, discrimination, and/or abuse related to their 
LGBTQ/DSD status.12,47,48 In addition, many DSD-a ected individuals have had unneces-
sary and/or painful and invasive surgeries, and their DSD status was withheld until well into 
adulthood.  ese traumatic experiences can lead to mistrust of the medical community. Caring 
for LGBTQ/DSD patients requires providers to realize the ubiquity of trauma, recognize the 
symptoms and signs of trauma, acknowledge its e ects, and shift from a pathologizing stance of 
“What’s wrong with you?” to the much more helpful “What happened to you, and how can I 
help you cope best?” A trauma-informed approach can improve interactions with all patients.49
SCREENINGS
No genetic di erences predispose members of the LGBTQ community to diseases. Di erences 
in disease burden can thus be linked to adverse healthcare experiences, consequent avoidance 
of preventive care, provider ignorance about necessary screenings for di erent populations, lack 
of insurance, and increased health risk behaviors (which often represent attempts to cope with 
sex- or gender-related minority stress). Some sex-speci c or demographic-speci c recommenda-
tions do not perfectly apply to LGBTQ individuals due to insu  cient research. Best practices 
must therefore be extrapolated based on a combination of clinical consensus and what is known 
about the pathophysiology of disease. Providers should therefore have and document “informed 
consent” discussions with patients (see Part II) in order to choose the best treatment course.50 
Many screening and preventive practices are best guided by reported patient behavior—particu-
larly related to substance abuse, sexual practices, and mental health—rather than by identi cation 
with a particular patient population. For example, a gay male patient with the same monogamous 
male partner for 30 years who does not drink alcohol or use drugs, has no history of depression 
or anxiety, is stably employed, and reports no current problems may not bene t from some of the 
additional screenings often recommended for men who have sex with men, which are often based 
on those with multiple sex partners.  e sections below outline best behavior-based practices for 
the LGBTQ/DSD communities and all patients.
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Cancer Screenings – Decisions about cancer screening are complex and require consideration 
of multiple factors. Patient anatomy and the underlying cancer risk for speci c organs are factors 
to consider. Common cancer screening guidelines for asymptomatic adults without a personal or 
family history of cancer include:
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Few cancer databases collect data on sexual orientation or gender identity (but see  e PRIDE 
Study in Appendix A for research addressing this gap). However, evidence suggests that the 
LGBTQ community su ers from higher rates of certain cancers compared to straight, cisgender 
communities.  ese disparities may be caused by behavioral di erences (such as anal cancer in gay 
men67) or di erences in accessing preventive care (such as cervical cancer in lesbian women, who 
may visit the OBGYN less frequently because of not needing birth control68). Whether or not a 
person with a DSD is at an increased risk for malignancy depends on the speci cs of their DSD.  
Providers must therefore research the needs for speci c patients according to their past medical 
history, hormonal pro le, and present anatomy. 
Gender-a  rming care can a ect screening recommendations because some risk factors may be 
increased (trans women develop increased breast tissue while taking estrogen, requiring routine 
screening) or decreased (trans men do not need cervical pap tests after having a total hysterectomy 
removing the cervix).  is underscores the importance of establishing a trusting relationship with 
patients to gather a complete history that includes current anatomy to make appropriate cancer 
screening recommendations. Patient anatomy and the underlying cancer risk for speci c organs 
should be considered. For example, when considering cervical cancer screening, the  rst question 
should be “does this patient have a cervix?” but other factors such as time since last Pap test, prior 
abnormal cytology, sexual history, and underlying immunosuppressed state are also considered. 
When designing a cancer screening strategy for LGBTQ and DSD-a ected patients, evaluation of 
the traumatic versus a  rming nature of some invasive exams or procedures must also be con-
sidered and discussed with the patient.  e clinician should talk through the bene ts, risks, and 
alternatives with each patient, based on their individual anatomy as well as related risk behaviors. 
A mammogram on a trans man (FSAAB) who uses chest binding and has not had a mastectomy 
may be very disruptive but necessary if there is a strong family history of breast cancer; the same 
mammogram may also be medically necessary and seen as an identity-a  rming step in gender 
transition by a trans woman (MSAAB) who has had breast augmentation surgery, and takes 
hormones to supplement breast development. Note that providers may have to help patients  le 
claims with insurance companies if the patient has changed their gender identity on their identi -
cation but screenings do not align with gender identities expected by insurance companies (e.g., a 
prostate screening for a (trans) woman or a cervical screening for a (trans) man—see Part IV).  
Sexual Health Screening and Preventive Prescribing – Preventive health recommendations 
related to sexual health like regular HIV and STI screening are dependent on taking a full sexual 
history (see Part I). Nonjudgmentally determine speci c types of sexual behavior that the patient 
engages in (“what goes where?”) because vaginal, oral, anal, and other sexual practices carry 
di erent health risks for all populations. Many older adults are also sexually active but are often 
overlooked for sexual health screenings,69 which may contribute to STI transmission risks.70 
Determine how patients protect themselves from HIV, STIs, and unwanted pregnancies, as well 
as their (and ideally their partner’s) past history with any of these conditions.  It is also import-
ant to screen all patients for high-risk sexual behaviors, including alcohol/drug use during sex or 
exchanging sex for money, drugs, or housing.  is information is crucial to know for all patients, 
not just LGBTQ patients.
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PrEP and PEP – Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are 
biomedical treatments that lower a person’s risk of contracting HIV. PrEP is a daily, oral medica-
tion prescribed to HIV-negative patients who disclose high-risk behaviors (e.g., unprotected sex 
with one or more people who are HIV positive or whose HIV status is unknown, sex under the 
in uence of drugs/alcohol, injection drug use) and want to decrease their risk of contracting HIV. 
PrEP is over 90% e ective at preventing HIV transmission, but its e ectiveness is greatly reduced 
if it is not consistently taken.71 Patients taking PrEP still need to use condoms to prevent trans-
mission of other STIs. PEP is antiretroviral drugs taken as an emergency intervention within 72 
hours of exposure to a high-risk event to reduce the likelihood of HIV seroconversion.72 
When physicians learn about high-risk behaviors, they often counsel the patient to stop the 
behavior. However, behavioral choices about sex and substance use are extremely complex. Many 
patients continue high-risk behaviors for a variety of reasons, including pleasure, a ection, physi-
cal connection, substance addiction, and/or exchange for resources. One recommended strategy is 
to nonjudgmentally assess how much the patient knows about HIV, then educate that individual 
as needed about which behaviors carry a higher risk of contracting HIV and how to decrease the 
risk of infection by taking medication (PrEP) daily.  is gives a patient the option to express the 
desire to try medication as a risk-reducing strategy recommended by their doctor. As with cross-
sex hormone therapy, physicians unfamiliar with prescribing HIV-related medications usually 
overestimate the risk associated with taking PrEP/PEP.  e Fenway Institute has a PrEP Action 
Kit with information about prescribing and monitoring PrEP,73 and it is crucial for providers to 
learn about the actual evidence for toxicity or adverse outcomes of PrEP/PEP and realistically 
contrast this with each patient’s risk of contracting HIV related to their exposure behavior. As 
with all preventive care and risk reduction strategies, providers should use behavioral rather than 
demographic or sexual/gender identity information when recommending HIV screening, PrEP, 
and PEP to patients. Cisgender straight patients who engage in the same high risk behavior (un-
protected sex with one or more people who are HIV positive or whose HIV status is unknown, 
sex under the in uence of drugs/alcohol, injection drug use) also bene t from HIV screening, 
PrEP, and PEP.
Providers should become comfortable discussing sexual history in 
a neutral, nonjudgmental way with all patients.  A thorough sexual 
history should be completed for every new patient in a primary 
care setting.  Remember to
1) indicate that all patients are asked this information,
2) describe how this information is used to provide them 
appropriate care, and





Current vaccination considerations are typically based on cis-normative demographic information 
that assumes behaviors. Multiple factors in uence a patient’s personal health risk, including their 
own practices as well as that of their current and previous partner(s).  e use of barrier methods 
during sexual activity may be low if partners cannot conceive or if an individual uses another 
form of birth control,74-76 thus increasing the risk of some disease transmissions.  erefore, rather 
than assessing risk based on demographic factors (such as whether a person identi es as LGBTQ), 
providers should determine risk based on the individual patient’s history and practices. However, 
any patient’s behavior could change at any time.  e provider should have a conversation about 
the implication of future behavior change if the provider (and/or the patient) were to determine 
that vaccination is not indicated at this time. Regional recommendations may vary depending on 
local outbreaks (e.g., current outbreaks of Hepatitis A for the general population in Kentucky77 
and meningitis outbreaks among men who have sex with men in New York City78).  e following 
page shows behavior-based recommendations for some common vaccinations.
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REPRODUCTION AND FAMILY PLANNING
Some aspects of reproduction and family planning have special considerations for LGBTQ/DSD 
individuals. It is important to avoid making assumptions about LGBTQ/DSD patients’ parent-
ing desires. Instead, ask about their goals, then help them determine their parenting options. 
 ese patients experience multiple obstacles to becoming parents, such as  nancial burdens (e.g., 
the cost of fertility treatments, surrogacy, or adoption), social challenges (e.g., discrimination of 
reproductive endocrinology programs and adoption agencies), and legal hurdles (e.g., adoption 
rights by LGBTQ people is being litigated in some states, and local laws regarding surrogacy and 
donor gametes vary). However, all major professional health organizations have issued statements 
supporting adoption and parenting by LGBTQ individuals.85 In addition, providers should be 
aware of the many microaggressions experienced by LGBTQ patients related to family planning 
(such as asking “Who’s the real mother?” or “Did you use a sperm donor?”—see Part I). For 
LGBTQ families, providers can avoid using the names “mother” and “father” until they establish 
what terminology the parents use at the  rst visit. Support, a  rmation, and acceptance is crucial 
in a world that often perceives LGBTQ/DSD people as di erent or objects of inappropriate and 
invasive curiosity.  
Contraception – Understanding sexual behavior of patients is important to determine what, 
if any, contraception is needed (in addition to safe-sex practices). For DSD-a ected patients, 
providers must discuss contraception goals and suitability for the speci c patient dependent on 
past medical history, hormonal pro le, and present anatomy. Sexual exploration with partners of 
male, female, or another gender is extremely common (particularly among LGBTQ youth86,87), 
and unplanned sexual encounters can and do occur. Emergency contraception is a critical part of 
preventive care planning for patients who might conceive and do not wish to become pregnant, 
and thus all patients should be made aware of emergency contraception as an option for current 
or potential future sexual encounters. 
Although testosterone use typically prevents menses in patients on the female-to-male spectrum 
who retain their natal reproductive organs, an ovulatory state with testosterone use is not uncom-
mon—thus making it is possible for trans men to become pregnant. Progestin and estrogen-pro-
gestin hormonal birth control options may interfere with hormone therapy for transgender pa-
tients, and many trans men are hesitant to use hormonal birth control even if they are not taking 
testosterone. Nonhormonal options, such as a copper intrauterine device (IUD), may be the best 
Providers should a irm identities while counseling about contraception. 
You can address contraception for patients who identify as gay or 
lesbian and describe a history of only same-sex sexual encounters by 
validating the patient’s current/past sexual behavior and indicating that 




option to discuss (although a discussion regarding heavy bleeding associated with copper IUDs is 
necessary). Barrier methods, including condoms or diaphragms, are other nonhormonal contra-
ception options (keeping in mind that diaphragms do not provide STI protection and have higher 
failure rates than other listed methods88). Similarly, estrogen use typically slows spermatogenesis in 
male-to-female spectrum patients, but the patient may still produce sperm and theoretically could 
impregnate a partner with a uterus.  us, all transgender patients taking hormone therapy should 
be counseled about contraception to determine the best options for them.
Fertility – DSD is associated with lower fertility, but in practice this will be highly patient-depen-
dent.89 For transgender patients taking hormones, fertility may be reduced with hormone use, and 
the reversibility of these e ects are not de nitively understood. It is advised that the provider ex-
plore family planning goals and e ects on fertility before the patient transitions.8  is is challeng-
ing for providers caring for transgender youth and will likely require subspecialty and counseling 
expertise.6 If a trans man desires to become pregnant, he should be advised to cease testosterone 
use before attempting to become pregnant because of adverse e ects on the fetus. Fertility pres-
ervation options for transgender patients desiring to start (and not later cease) hormone therapy 
include cryopreservation (“banking”) of sperm, oocyte, embryo, and ovarian or testicular tissue.6,90
Family Planning Options – Like the broader population, LGBTQ/DSD people who want to 
parent have multiple options for achieving this goal. Unlike many non-LGBTQ/DSD people, 
they are impacted by “social infertility,” as they are unable to conceive because of social, rather 
than solely medical factors.91  e following table details concepts of assisted reproduction and the 
primary ways LGBTQ/DSD people become parents.  e diversity of LGBTQ/DSD individuals 
and families means that a clinician cannot make assumptions about how a given LGBTQ/DSD 
identity becomes a family. Instead, providers should familiarize themselves with options available 
and ask for details as appropriate. Providers should be aware that not all options are available 
in all communities, and many are not covered by most health insurance policies and thus may 
be cost-prohibitive. New options (e.g., mitochondrial donation/three parent IVF) may become 
available in the future.
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Providers who care for children should be aware of the needs of 
LGBTQ parents. Historically, LGBTQ parents had di iculty establishing 
full rights for both parents. When such recognition was possible, it 
usually involved prohibitively expensive legal procedures. While legal 
recognition of LGBTQ families has improved, some LGBTQ people 
do not have access to these processes. Lack of such recognition 
is problematic in the health care setting, as LGBTQ parents may be 
asked to “prove” their relationship to their children in order to seek 
treatment for them. LGBTQ parents are parents regardless of whether 
they have a genetic link to their children. Some health concerns and 
questions are related to genetics, but many are not. Communicate 
with LGBTQ parents on why genetic history may be relevant. Ask 
questions about genetics and family formation with sensitivity, and 
remain open and welcoming to the input of all parents, regardless of 
their genetic link to the child.
Developing skills around inclusive communication regarding family 
and reproduction (see Part 1) will benefit all of your patients, as 
non-LGBTQ parents also form families through adoption, surrogacy, 





PART IV: SOCIAL DETERMINANTS OF HEALTH
SOCIAL DETERMINANTS OF HEALTH
Social determinants of health (SDOH) are structural factors that impact health, such as condi-
tions in which an individual grows up or lives (see  gure for some examples).  ese factors can 
in uence the psychological and physical well-being of patients. As a physician, it is important 
to screen all patients and determine when it is appropriate to call in housing, social, or other 
interprofessional support for patients. Providers should educate themselves about what services are 
available in their city or region and consult these services if they feel that the patient is at imme-
diate risk of hurting themselves or at risk of being hurt by their living conditions.  e American 
Academy of Family Physicians EveryONE project93 (see Appendix A) has excellent screening 
resources for social needs.
Much of the information regarding SDOH is related to systemic factors and understanding 
non-medical in uences in LGBTQ/DSD patient health. Every preventive health visit needs to 
revisit questions of social determinants of health for all patients.  Providers should avoid the as-
sumption that an individual’s living situation, employment, relationships, risk behaviors, or iden-
tities remain static from visit to visit. Below are additional considerations that a ect the psycho-
logical and social aspects of patients’ health. Because of the high prevalence of some psycho-social 
issues in the LGBTQ/DSD population, providers should make LGBTQ/DSD patients aware of 
the availability of mental health, substance abuse, intimate partner violence, and social support 
services if they or someone they know ever needs to access these services. Providers who work in 
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a setting without an up-to-date, single-source list of community resources will need to rely on 
internet searches and real time networking with other providers and community organizations 
to  nd the right resource(s) for patients. If social work and/or case management services through 
the provider’s clinic are available, the provider should attempt to set up a social work consultation 
and connect to social services to address any SDOH concerns by using healthcare systems tools to 
provide interdisciplinary support.  e following table provides an overview of SDOH that impact 
all patients, with particular relevance to LGBTQ and/or DSD-a ected people. (See Appendix A 
for follow-up resource links).
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LEGAL AND INSURANCE CONSIDERATIONS 
When making recommendations to patients, insurance coverage or lack thereof is an important 
consideration. LGBTQ individuals are less likely to be insured than cis/heterosexual counter-
parts.12,105 Services based on behavior may also fall outside of demographic-based guidelines (e.g., 
anal pap tests). Providers should familiarize themselves with coverage policies regarding these 
recommendations so that they may 1) have an informed conversation with patients to allow them 
to consider the bene t of screening versus potential out-of-pocket costs and 2) help patients apply 
to the insurance provider for an exception to noncovered services with an appropriate rationale 
outside the guidelines. If noncovered services are una ordable for a patient, providers should 
consider whether there are other measures that the patient could take to lower their risk. Provid-
ers should also reach out to clinic case management services to identify resources.  e Centers 
for Medicare and Medicaid Services (CMS) and  e National Uniform Billing Committee have 
approved a special billing code (condition code 45 - Ambiguous Gender Category) to alleviate 
situations where claims are incorrectly denied for transgender and DSD-a ected bene ciaries 
because of a mismatch between the gender marker and the billing service.108
Structural barriers that a ect LGBTQ and DSD health include legal and insurance policies that 
allow discrimination against LGBTQ and DSD-a ected individuals. Many of these policies vary 
from state to state, but providers should be aware of policies such as unequal, patchwork, and 
cost–prohibitive insurance coverage for domestic partnerships in private and public sectors; em-
ployer-based insurance that allows discrimination for sex and gender minorities; Title IX coverage 
of gender identity; and state-by-state policies allowing discrimination based on sexual orientation 
and/or gender identity for job, housing, and some public services. Other public policies have 
shown growth, including LGBTQ health included as federal priority in Healthy People 2020. 
Expanded A ordable Care Act (ACA) regulations and insurance access allowed many people 
who had not previously received coverage to do so, including those with preexisting conditions; 
protections against insurance discrimination for sex and gender minorities (ACA Section 1557) 
also improved coverage for many LGBTQ individuals. However, many of these policies are in 
 ux, so providers will need to determine how changes to public policy a ect their LGBTQ and 
DSD-a ected patients.
Name and gender-change processes for identi cation documents can be prohibitively complicated 
and expensive for transgender patients. One third of transgender people have not updated any 
IDs after transitioning,12 and many encounter insurance and legal issues (e.g., starting jobs, travel-
ing) when 1) their used name does not match their legal name or appearance or 2) when ordered 
preventive/diagnostic care does not match the sex on insurance identi cation (but see above). 
For the patient, navigating these systems can be a signi cant source of stress. Trans social support 
networks and advocacy groups are excellent resources for advice and supportive services. State-by-
state ID policies can be found at the National Center for Transgender Equality (see Appendix A).
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To change some identification documents, transgender patients must 
obtain a letter from their provider confirming their gender transition. 
Providers should indicate that the patient “has transitioned” under the 
provider’s care rather than “is transitioning.” The language used in the 
letter is consequential, and it is important to refer to the transition in past 
tense. For example, adult patients with a past-tense letter will be issued 
a standard 10-year passport, whereas with a present-tense letter only a 




PART V: SENSITIVE PHYSICAL EXAMS
KNOW YOUR PATIENT
Physical examinations, particularly of sensitive parts of the body, such as genitals or breasts/chest, 
can be distressing to any patient.  ese exams can be more challenging for patients who have 
experienced trauma (e.g., sexual abuse), mistreatment (e.g., voyeuristic or inappropriately curious/
intrusive behavior from previous providers), or gender dysphoria (e.g., the existence of body parts 
that do not match an individual’s gender identity).  
To prepare for sensitive exams, the provider should discuss why the exam is important and ask 
about the patient’s experiences with previous exams.7  is enables the provider to address any 
anxiety the patient feels about proceeding with the exam and discuss options to make their experi-
ence less stressful. It is important to note that not all LGBTQ patients and individuals born with 
DSD have experienced trauma, but the guiding principles of trauma-informed care for physical 
exams can help build a trusting relationship between providers and all patients.109  ey include
1) placing control over consent to the exam and ability to stop the exam with the patient,
2) engaging in shared decision-making of examination options (positioning, chaperones, 
etc.),
3) explaining the procedure by narrating each step and using preferred terminology,
4) informing the patient that modi cations to the procedure are available, and
5) acknowledging and validating a history of trauma and/or previous negative experiences.
INCLUSIVE LANGUAGE FOR EXAMS AND ENCOUNTERS
Mirroring a patient’s own language in regard to anatomical terms can facilitate comfort during 
sensitive exams, particularly for patients who providers have established are not cisgender. During 
initial discussions, providers should ask patients how they refer to their body parts or speci c 
bodily functions since language used will be patient-speci c (“What language do you typically 
use when talking about your body?”). For patients who are on the male-to-female spectrum or 
female-to-male spectrum, providers should also choose words that are less gendered to provide a 
less stressful environment for a medical history and/or exam. Examples include:
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Other language choices can help optimize the comfort of patients during sensitive exams:
STRATEGIES AND OPTIONS TO OPTIMIZE COMFORT
Trauma-informed care (see Part III) involves empowerment, voice, and choice. In addition to 
language choices, there are other ways for providers to optimize comfort for all patients during 
sensitive exams, including o ering alternative screening options compared to more invasive clin-
ical screenings (see the following page). General strategies also include allowing other providers 
(e.g., of a di erent gender) to perform the test, allowing the patient to bring a support person to 
the appointment, and ensuring that the patient understands that they can ask to stop the exam.7 
Many postoperative transgender patients and DSD-a ected individuals report that providers have 
allowed students or other providers to watch sensitive examinations or perform an additional 
examination.38,39  is is a signi cant problem because it dehumanizes and objecti es patients. 
Providers have a responsibility to prevent this voyeuristic behavior, even in the context of teach-
ing. If it is appropriate for a learner to be present, the provider should ask for the permission of 
the patient and limit the number of learners in the room. Before any exam, the provider should 
also discuss how the patient can stop the exam if necessary. If an exam is stopped due to patient 
distress, the provider should ensure that the patient has ample opportunity to reconstitute and has 
a  rm self-care plan before leaving the o  ce.110
Gynecologic and Genitourinary Exams – Pelvic exams and cervical screenings are part of rou-
tine care, but they can feel invasive to many patients. Bimanual exams are indicated in symptom-
atic patients (e.g., pelvic pain) but not for screening asymptomatic patients.57 For patients who 
feel uncomfortable with gynecologic exams, various steps make the experience more comfortable 
for the patient.110  e clinic should identify patient preferences toward the gender of the pro-
vider and/or chaperone, if desired; it’s important to make sure that required chaperones are not 
Trauma-informed care involves empowerment, voice, and choice.  
This benefits all patients, regardless of their past experiences and 
medical history.  The principles of trauma-informed care can improve 




perceived as voyeurs.  e provider can make accommodations such as allowing the patient to only 
partially undress or not requiring use of foot rests or a lithotomy position. If discomfort or pain is 
a concern, the provider can use a small or pediatric speculum or an anoscope rather than a vaginal 
speculum. Low-dose topical estrogen can be administered to patients for one to two weeks before 
the exam to reduce cervical atrophy, although patients on the female-to-male spectrum may not 
want to introduce estrogen into their bodies. For male-to-female spectrum patients, a gynecologic 
exam can be a  rming for those who have a neovagina. Other patients may “tuck” their testicles 
into the inguinal canal and penis/scrotum posteriorly in the perineal region, which can cause 
complications like urinary trauma or hernias.6 Sensitively asking patients about the role of tucking 
in their well-being and any concerns allows the provider to educate about safety (e.g., not tucking 
as tightly).111 
Anal/Rectal Exams – Comfort can be increased by ensuring that the patient maintains the locus 
of control during the exam and giving the patient options. Positioning for anal or rectal exams 
can be done standing, leaning, lying on the side, supine, and supine with the feet together and 
knees apart to expose the perineum. In practice, clinicians examining cis men usually perform 
digital rectal exams standing, although studies suggest that these patients actually prefer having 
the exam lying on their side.112 Providers should use adequate lubricant, describe all steps of the 
procedure to the patient, and ask permission prior to proceeding.
Breast/Chest exams – Clinical breast exams are no longer recommended for routine cancer 
screening in asymptomatic patients,54 but patients may present with conditions that indicate 
breast or chest examination. Providers should apply the same principles of trauma-informed care 
described above to breast and chest exams: explain the purpose and steps of the exam, obtain 
permission, proceed matter of factly, let the patient stop at any time, and use inclusive language. 
To create a  at chest appearance, some patients on the female-to-male spectrum may bind their 
chests with tight  tting sports bras, bandages, or binders created speci cally for this purpose. 
 ese products may irritate the chest skin, cause fungal infections, and lead to other health 
issues.113 Providers are advised to discuss binding practices and work with the patient to mitigate 
risk (e.g., by recommending “o  days” if possible or hygienic practices to avoid infections).6,113  
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Alternatives to Clinical Exams – In some cases, patients may be able to complete routine testing 
through at-home sample collections rather than at a healthcare facility.  ese options could be 
desirable for patients who may feel uncomfortable in certain healthcare settings (e.g., frontal 
self-swabs for HPV for trans men who may feel uncomfortable visiting a gynecologist’s o  ce and 





At the end of the content section of this manual, you should now be ready to employ the best 
practices that you have learned in this manual. As a reminder, this intervention is meant to pro-
vide a nuts and bolts approach to LGBTQ health—you will learn much more by having thought-
ful, open conversations with all of your patients.
Appendix A includes several nationally-renowned and evidenced-based resources to close any re-
maining knowledge gaps or to allow for more in-depth exploration of speci c topics.  One of the 
best “go-to” resources is  e National LGBT Health Education Center (part of the Fenway Insti-
tutute), which is an established resource for LGBTQ healthcare and has excellent online resources 
for providers and patients. For speci cs on transgender clinical care,  e World Professional 
Association for Transgender Health (WPATH) and  e Center of Excellence for Transgender 
Health out of the University of California, San Francisco provide detailed, evidence-based clinical 
recommendations and research summaries. You will  nd links to these and other comprehensive 
resources on the following page.
LGBTQ health is a rapidly evolving area, so providers must be sure to 
use lifelong learning skills to keep updated as new research findings 
and best practices emerge.  The goal is to always aspire to provide the 





APPENDIX A - NATIONAL RESOURCES 
LGBTQ/DSD HEALTHCARE RESOURCES FOR PROVIDERS AND PATIENTS
 ese comprehensive, de nitive healthcare resources can supplement your primer on LGBTQ/
DSD health, and many provide excellent information for patients as well.
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LGBTQ/DSD COMMUNITY AND SUPPORT RESOURCES 
Below are resources for LGBTQ/DSD patients, including national and regional organizations. 
Visit the eQuality website (louisville.edu/medicine/equality/) for a full list of local and regional 
resources for Louisville, Kentucky. For providers and medical educators outside of Louisville, local 
resources can be found by contacting a  liated campus LGBTQ student services or by contacting 
a local LGBTQ services center, which can be identi ed through the CenterLink LGBT Commu-
nity Center Member Directory (https://www.lgbtcenters.org/LGBTCenters).
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APPENDIX B – GLOSSARY
De nitions are sourced and adapted from  e Safe Zone Project.120
Ally – (noun) a (typically straight‐ or cis‐identified) person who supports and respects members of 
the LGBTQ community. While the word does not necessitate action, we consider active allies to be 
people who take action upon this support and respect, which also demonstrates to others that you 
are an ally. 
Asexual – (adjective) having a lack of (or low level of) sexual attraction to others and/or a lack of 
interest or desire for sex or sexual partners. 
Biological Sex – (noun) a medical term used to refer to the chromosomal, hormonal and anatomical 
characteristics that are used to classify an individual as female or male or intersex. Often referred to 
as simply “sex,” “physical sex,” “anatomical sex,” or specifically as “sex assigned [or designated] at 
birth (SAAB).” 
Bisexual – (adjective) a person emotionally, physically, and/or sexually attracted to male/men and 
females/women. Other individuals may use this to indicate an attraction to individuals who identify 
outside of the gender binary as well and may use bisexual as a way to indicate an interest in more 
than one gender or sex (i.e. men and genderqueer people). This attraction does not have to be equally 
split or indicate a level of interest that is the same across the genders or sexes an individual may be 
attracted to. 
Cisgender – (adjective, pronounced “siss‐jendur”) a person whose gender identity and biological sex 
assigned at birth align (e.g., man and male‐assigned). A simple way to think about it is if a person is 
not trans, they are cisgender. The term “cisgendered” is a common mistake. 
Cisnormativity – (noun) the assumption, in individuals or in institutions, that everyone is cisgender, 
and that cisgender identities are superior to trans identities or people. Leads to invisibility of noncis-
gender identities. 
Coming Out – (verb) (1) the process by which one accepts and/or comes to identify one’s own sexu-
ality or gender identity (to “come out” to oneself). (2) The process by which one shares their sexuality 
or gender identity with others (to “come out” to friends, etc.). 
Di erences of Sexual Development (DSD) - (noun) someone whose combination of chromosomes, 
gonads, hormones, internal sex organs, and genitals di ers from the two expected patterns of male or 
female; sometimes referred to as intersex; formerly known as hermaphrodite (or hermaphroditic), but 
these terms are now considered outdated and derogatory. Some texts still use “Disorders” of Sexual 
Development for DSD, which patients also find demeaning.
Feminine Presenting; Masculine Presenting ‐ (adjective) a way to describe someone who ex-
presses gender in a visibly feminine or masculine way (for example in hair style, demeanor, clothing 
choice, or style) that is characteristic or associated with the gender concepts in a given society. 
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FSAAB – (adjective) abbreviation for female sex assigned at birth.
FtM/F2M; MtF/M2F – (adjective) abbreviation for female‐to‐male transgender person; abbreviation 
for male‐to‐female transgender person. 
Gay – (adjective) (1) a term used to describe individuals who are primarily emotionally, physically, 
and/or sexually attracted to members of the same sex and/or gender. More commonly used when 
referring to males/men‐identified people who are attracted to males/men‐identified people, but can 
be applied to females/women‐identified people as well. (2) An umbrella term used to refer to the 
queer community as a whole, or as an individual identity label for anyone who does not identify as 
heterosexual. 
Gender A irming Surgery – (noun) surgical options that alter a person’s biological anatomy. “Sex 
Reassignment Surgery” was a term used by some medical professionals, but gender a irming 
surgery is considered to be a more appropriate term. Some people refer to the di erent surgical 
procedures as “top” surgery (construction of a male‐type chest or breast augmentation for a female‐
type chest) and “bottom” surgery (various genital reconstruction surgeries that can involve genital 
removal and/or genital construction) to discuss what type of surgery they are having without having 
to be more explicit.
Gender Binary – (noun) the idea that there are only two genders – male/female (or man/woman) 
and that a person must be strictly gendered as either/or. 
Gender Expression – (noun) “gender presentation” or the external display of one’s gender through 
a combination of dress, demeanor, social behavior, and other factors; generally measured on scales 
of masculinity and femininity. Note that gender expression may not always match a person’s actual 
gender identity (i.e., you can’t always know someone’s gender identity by looking). Some people may 
also express a gender because of safety or work/family/social expectations, but may actually have a 
di erent gender identity than that presented.
Gender Fluid ‐ (adjective) gender fluid is a gender identity best described as a dynamic mix of male 
and female. A person who is gender fluid may always feel like a mix of the two traditional genders, 
but may feel more man some days, and more woman other days. 
Gender Identity – (noun) the internal perception of one’s gender, and how they label themselves, 
based on how much they align, or do not align, with what they understand their options for gender to 
be. Common identity labels include man, woman, genderqueer, trans, and more. 
Gender Non‐Conforming (GNC) ‐ (adjective) someone whose gender presentation, whether by 
nature or by choice, does not align in a predictable fashion with gender‐based expectations. 
Genderqueer ‐ (adjective) a gender identity label often used by people who do not identify with the 
binary of man/woman; or as an umbrella term for many gender nonconforming or nonbinary identi-
ties (e.g., agender, bigender, genderfluid). 
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Heteronormativity – (noun) the assumption, individually or institutionally, that everyone is hetero-
sexual, and that heterosexuality is the norm or is superior to all other sexualities; can lead to the 
invisibility or stigmatizing of other sexualities. Often included in this concept is a level of gender 
normativity and gender roles, the assumption that individuals should identify as men and women, 
and be masculine men and feminine women, or that men and women are the expected complemen-
tary pair. 
Heterosexual – (adjective) a person primarily emotionally, physically, and/or sexually attracted to 
members of the opposite sex. Also known as straight. 
Homophobia/Biphobia/Transphobia – (nouns) umbrella terms for a range of negative attitudes 
(e.g., fear, anger, intolerance, resentment, erasure, or discomfort) and policies that an individual or in-
stitution may have against members of LGBTQ community. The term can also connote a fear, disgust, 
or dislike of being perceived as LGBTQ. 
Homosexual – (adjective) a [medical] term used to describe a person primarily emotionally, physical-
ly, and/or sexually attracted to members of the same sex/gender. This term is considered stigmatizing 
due to its history as a category of mental illness, and is discouraged for common use (use gay or 
lesbian instead). 
Lesbian – (noun) a term used to describe women attracted romantically, erotically, and/or emotional-
ly to other women. 
MSAAB – (adjective) abbreviation for male sex assigned at birth. 
MSM/WSW ‐ (noun) initialisms for “men who have sex with men” and “women who have sex with 
women,” to distinguish sexual behaviors from sexual identities (e.g., because a man is straight, it 
doesn’t mean he’s not having sex with men). 
Nonbinary - (adjective) umbrella term for genders that are not exclusively male/female (such as 
agender, bigender, genderfluid, genderqueer), and for individuals who may identify as nonbinary.
Outing – (verb) involuntary or unwanted disclosure of another person’s sexual orientation, gender 
identity, or intersex status. 
Questioning –  (verb, adjective)  exploring one’s own sexual orientation or gender identity or an 
individual who is exploring their own sexual orientation and gender identity. 
Queer – (adjective) used as an umbrella term to describe individuals who don’t identify as straight; 
also used to describe people who have nonnormative gender identities. Queer is not used or em-
braced by all LGBTQ community members due to its historical derogatory use, but through linguistic 
reclamation it is indeed self-used by many LGBTQ community members. 
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Sex Assigned at Birth (SAAB) – (noun) a phrase used to distinguish between the sex that was 
assigned to an individual (typically male or female) and gender identity, which may not be the same. 
Same Gender Loving/SGL – (adjective) a term traditionally used by members of the African‐Amer-
ican/Black community to express an alternative sexual orientation without the perceived social or 
political implication of the term gay or lesbian. 
Sexual Orientation – (noun) the type of sexual, romantic, emotional/spiritual attraction one feels for 
others, often labeled based on the gender relationship between the person and the people they are 
attracted to (often mistakenly referred to as sexual “preference”).
Third Gender – (noun) a person who does not identify with either man or woman, but identifies with 
another gender. This gender category is used by societies, both contemporary and historic, that rec-
ognize three or more genders; is also a conceptual term meaning di erent things to di erent people 
who use it as a way to move beyond the gender binary. 
Trans/Transgender – (adjective) (1) an umbrella term covering a range of identities that transgress 
socially defined gender norms or (2) a person who lives as a member of a gender other than that 
expected based on sex assigned at birth. 
Transition(ing) – (noun, verb) primarily used to refer to the process a trans person undergoes when 
changing their bodily appearance either to be more congruent with the gender/sex they feel them-
selves to be and/or to be in harmony with their preferred gender expression. 
Two‐Spirit – (noun) is an umbrella term traditionally used by Native American people to recognize 
individuals who possess qualities or fulfill roles of both genders.
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